The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen Staphylococcus aureus

Antibiotics (Basel). 2023 Feb 7;12(2):343. doi: 10.3390/antibiotics12020343.

Abstract

The ESKAPEE bacterial pathogen Staphylococcus aureus has posed a serious public health concern for centuries. Throughout its evolutionary course, S. aureus has developed strains with resistance to antimicrobial agents. The bacterial pathogen has acquired multidrug resistance, causing, in many cases, untreatable infectious diseases and raising serious public safety and healthcare concerns. Amongst the various mechanisms for antimicrobial resistance, integral membrane proteins that serve as secondary active transporters from the major facilitator superfamily constitute a chief system of multidrug resistance. These MFS transporters actively export structurally different antimicrobial agents from the cells of S. aureus. This review article discusses the S. aureus-specific MFS multidrug efflux pump systems from a molecular mechanistic perspective, paying particular attention to structure-function relationships, modulation of antimicrobial resistance mediated by MFS drug efflux pumps, and direction for future investigation.

Keywords: ESKAPEE; Staphylococcus aureus; bacterial pathogens; major facilitator superfamily; multidrug efflux; multidrug resistance; transporter proteins.

Publication types

  • Review

Grants and funding

The investigations considered here that were reported from our research laboratories were supported in part with grants from the National Institute of General Medical Sciences (P20GM103451), the National Institutes of Health, the US Department of Education, HSI-STEM (P031C110114), and internal research grants (IRG) from ENMU.